Skip to main content

Table 1 Patient information

From: Genomic signatures characterize leukocyte infiltration in myositis muscles

Subject ID Age Gender Disease type* Muscle Disease duration (months) Treatments
GEIM12 74 F DM Biceps 1 None
GEIM54 62 M PM Quadriceps 24 None
GEIM57 38 F Normal Biceps N/A N/A
GEIM63 37 F Normal Biceps N/A N/A
GEIM64 77 M NM Biceps 6 Pred
GEIM90 90 M PM Deltoid 3 None
GEIM96 86 F PM Biceps 3 None
GEIM127 68 F IBM Biceps 36 Azathioprine
GEIM133 60 F Normal Quadriceps N/A N/A
GEIM174 36 F PM Biceps 3 None
GEIM272 25 F DM (with PFA) Biceps 3 Pred x 4 days
GEIM306 64 F NM Biceps 17 Pred
GEIM312 76 F PM Biceps 96 None
GEIM315 39 F DM Biceps 3 None
GEIM322 58 F PM Biceps 180 None
GEIM331 87 F PM Deltoid 36 Pred
GEIM335 71 F IBM Quadriceps 24 None
GEIM340 83 F NM Biceps 66 Pred
GEIM349 28 F DM Biceps 18 Pred, Azathioprine
GEIM354 76 M IBM Biceps 60 None
GEIM363 79 F IBM Biceps 36 None
GEIM365 41 M Normal Biceps N/A N/A
GEIM368 61 F Normal Quadriceps N/A N/A
GEIM372 61 M IBM Quadriceps 84 Dexamethasone taper
GEIM373 80 F IBM Quadriceps 90 None
GEIM374 47 F IBM Quadriceps 54 None
GEIM375 50 F NM Quadriceps 6 None
GEIM376 37 M DM Deltoid 4 None
GEIM377 50 M IBM Biceps 24 None
GEIM380 61 M IBM Quadriceps 24 None
GEIM382 30 F DM (with PFA) Deltoid 1 None
GEIM383 44 F DM (with PFA) Deltoid 2 Pred x 1 month
GEIM385 61 F PM Biceps 60 Etancercept
GEIM389 40 M DM (with PFA) Biceps 5 N/A
GEIM391 71 M NM Quadriceps 7 None
GEIM397 77 M IBM Biceps 84 None
  1. * DM, dermatomyosits; PM, polymyositis; IBM, inclusion body myositis; PFA, perifascicular atrophy.